enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. List of antiretroviral fixed-dose combinations - Wikipedia

    en.wikipedia.org/wiki/List_of_antiretroviral...

    Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.

  3. FDA approves 1st long-acting HIV drug combo, monthly shots - AOL

    www.aol.com/news/fda-approves-1st-long-acting...

    U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus. Thursday’s approval of ...

  4. U.S. FDA approves Gilead's long-acting HIV drug Sunlenca - AOL

    www.aol.com/lifestyle/u-fda-approves-gileads...

    U.S. FDA approves Gilead's long-acting HIV drug Sunlenca December 22, 2022 at 11:26 AM FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California

  5. Etravirine - Wikipedia

    en.wikipedia.org/wiki/Etravirine

    In January 2008, the US Food and Drug Administration (FDA) approved its use for people with established resistance to other drugs, making it the 30th anti-HIV drug approved in the United States and the first to be approved in 2008. [5] It was also approved for use in Canada in April 2008. [6]

  6. Ritonavir - Wikipedia

    en.wikipedia.org/wiki/Ritonavir

    Ritonavir is sold as Norvir by AbbVie, Inc. [4] [5] The US Food and Drug Administration (FDA) approved ritonavir on March 1, 1996, [41] [42] As a result of the introduction of "highly active antiretroviral thearap[ies]" the annual U.S. HIV-associated death rate fell from over 50,000 to about 18,000 over a period of two years. [40]

  7. Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA ...

    www.aol.com/news/long-acting-hiv-treatment...

    The FDA has approved ViiV Healthcare's Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option, to reduce the risk of sexually acquired HIV-1. The long-acting ...

  8. FDA Approves First Injectable For HIV Pre-Exposure ... - AOL

    www.aol.com/news/fda-approves-first-injectable...

    The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension) for use in adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure ...

  9. Darunavir - Wikipedia

    en.wikipedia.org/wiki/Darunavir

    It is of the protease inhibitor (PI) class and works by blocking HIV protease. [1] Darunavir was approved by the US Food and Drug Administration (FDA) in June 2006. [6] [7] It is on the World Health Organization's List of Essential Medicines. [8] It is available as a generic medication. [9]